Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In December: Earnings Summary

TRACON Pharmaceuticals

05/03/2024 23:36

* TRACON Pharmaceuticals Inc  TCON.OQ  reported quarterly
adjusted
earnings of 1 cent​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -31 cents.  The mean expectation of
three analysts for the quarter was for a loss of 8 cents per
share. Wall Street expected results to range from -11 cents
to -3 cents per share.
    * Reported revenue was zero​; analysts expected $1.00
million. 
    * TRACON Pharmaceuticals Inc's reported EPS for the quarter
was 1
cent​.
    * The company reported quarterly net income of $439
thousand.
    * TRACON Pharmaceuticals Inc shares had risen by 7.7% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 23.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $4.00 
This summary was machine generated from LSEG data March 5 at
11:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.08          0.01           Beat
 Sep. 30 2023      -0.06          0.29           Beat
 Jun. 30 2023      -0.10          0.22           Beat
 Mar. 31 2023      -0.26          -0.36          Missed